10% owner NMSIC Co-Investment Fund sold 350,000 shares of XGN at $3.30 (-22% discount to current $4.24); stock unprofitable, -29.3% from 52-week high.
NMSIC Co-Investment Fund, a 10% owner of EXAGEN INC., sold 350,000 shares (16.6% reduction in holdings) at $3.30 per share on 2025-03-25, collecting $1,155,000.00. The transaction occurred at a 22% discount to the current price of $4.24, and notably preceded a recent 30-day rally of +22.9%. The company remains unprofitable with net income of $-5,028,000.00 in the latest quarter despite modest 5.9% annual revenue growth, suggesting the sale by a major shareholder occurred during a period of negative earnings and equity market conditions. The stock's 52-week trading range ($1.36–$6.00) and current position 29.3% below its high indicates persistent volatility and earlier market weakness at the time of sale.